Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Gac Med Mex ; 133(3): 253-8, 1997.
Artigo em Espanhol | MEDLINE | ID: mdl-9303875

RESUMO

A woman with acute fatty liver of pregnancy developed fulminant hepatic failure after delivery, a time when spontaneous recovery was expected. Pancreatitis and multiple organ failure was documented and intensive treatment in a critical care unit was needed to support organ function. She underwent plasmapheresis due to extreme hyperbilirubinemia and coma. She recovered completely.


Assuntos
Fígado Gorduroso/diagnóstico , Pancreatite/diagnóstico , Complicações na Gravidez/diagnóstico , Doença Aguda , Adulto , Terapia Combinada , Cuidados Críticos/métodos , Fígado Gorduroso/complicações , Fígado Gorduroso/terapia , Feminino , Humanos , Insuficiência de Múltiplos Órgãos/diagnóstico , Insuficiência de Múltiplos Órgãos/etiologia , Insuficiência de Múltiplos Órgãos/terapia , Pancreatite/etiologia , Pancreatite/terapia , Gravidez , Complicações na Gravidez/terapia , Transtornos Puerperais/diagnóstico , Transtornos Puerperais/etiologia , Transtornos Puerperais/terapia
5.
Acta Anaesthesiol Scand Suppl ; 107: 219-22, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-8599282

RESUMO

OBJECTIVE: To demonstrate that pentoxifylline (PTX) and not placebo improves oxygen consumption (VO2) in critically ill patients with severe sepsis. SETTING: Multidisciplinary intensive care unit in a university affiliated hospital. DESIGN: A randomized, double blinded clinical trial comparing 300 mg of PTX administered in a 120 min iv infusion with an identically looking placebo. PATIENTS: 13 patients (9 men and 4 women) average age 39 (24-62) years old received PTX, and 12 patients (5 men and 7 women) average age 38 (21-83) years old received placebo. All satisfied ACCP/SCCM criteria for severe sepsis. MEASUREMENTS AND INTERVENTIONS: Patients fulfilling criteria for severe sepsis was identified on admission, cardiac output, DO2 and VO2 were measured by thermodilution and standard oximetric technics after adequate volume replacement at baseline, 60 and 120 during infusion. F-test of analysis of variance was used to test hypothesis about differences of DO2 and VO2 by group, by time and for the interaction terms, a "p" value < 0.05 was considered significant. RESULTS: Evaluation of baseline measurements of both groups revealed no significant difference in any haemodynamic function or oxygen transport variables. The average VO2 difference (0-120 min) between groups was 21 mL/min.m2 and it was higher in the experimental group, however, this difference was non significant. CONCLUSION: We think that the trend in VO2 followed by the experimental group is clinically important. If this difference is sustained we will probably be able to demonstrate our hypothesis.


Assuntos
Infecções Bacterianas/tratamento farmacológico , Consumo de Oxigênio/efeitos dos fármacos , Pentoxifilina/uso terapêutico , Inibidores de Fosfodiesterase/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , Infecções Bacterianas/sangue , Débito Cardíaco/efeitos dos fármacos , Cuidados Críticos , Estado Terminal , Citocinas/antagonistas & inibidores , Método Duplo-Cego , Feminino , Humanos , Infusões Intravenosas , Masculino , Pessoa de Meia-Idade , Oxigênio/sangue , Pentoxifilina/administração & dosagem , Inibidores de Fosfodiesterase/administração & dosagem , Placebos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA